Evidence map›Paper›PMID 32372331›Full record

ArticleInternal and emergency medicine2021

The clinical importance of early acute hepatic porphyria diagnosis: a national cohort.

Yonatan Edel, Rivka Mamet, Sharon Cohen, Daniel Shepshelovich, Assi Levi, Iftach Sagy

Abstract read
PubMed Publisher
In one paragraph

Article in Internal and emergency medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. A Prospective, Blinded Study of Symptom Prevalence and Specificity of Porphyrin Precursors in Carriers of Acute Hepatic Porphyria.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yonatan EdelIsraeli National Service for the Biochemical Diagnoses of Porphyrias, Rabin Medical Center, Beilinson Hospital, 49100, Petah Tikva, Israel. yonatanad@clalit.org.il.ORCID http://orcid.org/0000-0001-6945-6434
Rivka MametIsraeli National Service for the Biochemical Diagnoses of Porphyrias, Rabin Medical Center, Beilinson Hospital, 49100, Petah Tikva, Israel.
Sharon CohenIsraeli National Service for the Biochemical Diagnoses of Porphyrias, Rabin Medical Center, Beilinson Hospital, 49100, Petah Tikva, Israel.
Daniel ShepshelovichInternal Medicine A, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
Assi LeviPhotodermatosis Service, Department of Dermatology, Rabin Medical Center, Petah Tikva, Israel.
Iftach SagyRheumatology Unit, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
Tel Aviv University · ILRabin Medical Center · ILBen-Gurion University of the Negev · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute hepatic porphyria (AHP) attacks begin with abdominal pain and can progress to severe life-threatening conditions. Early diagnosis and treatment may prevent these complications. We investigated the difference between the severity of porphyria attacks before and after porphyria diagnosis. A retrospective study including AHP patients hospitalized for an acute attack in Israel during a 15-year period. Diagnosis of an attack was based on typical clinical symptoms accompanied by at least one documented elevated urinary porphobilinogen above fourfold of normal values. The primary outcome was intensive care unit (ICU) admissions. Secondary outcomes included the length of hospital stay, severe hyponatremia, seizures, and psychiatric symptoms. 42 attacks in 9 patients were included. Most attacks occurred in women (78.6%) and in acute intermittent porphyria patients (76.2%). The mean age of attack was 26.5 (± 6.3) years. Attacks following porphyria diagnosis had a lower prevalence of ICU admission (3.3% versus 75.0%, p < 0.001), seizures (0% versus 50.0%, p < 0.001), psychiatric symptoms (23.3% versus 66.7%, p = 0.01), severe hyponatremia (16.7% versus 83.3%, p < 0.001), and median length of hospital stay (5 versus 11.0 days, p < 0.001). These results remained significant after simple univariate logistic regression for ICU admission [odds ratio (OR) 0.01, 95% confidence interval (CI) 0.00-0.12], prolonged hospital stay (OR 0.08, 95% CI 0.01-0.41), seizures or neurological symptoms (OR 0.06, 95% CI 0.01-0.30), and severe hyponatremia (OR 0.02, 95% CI 0.00-0.20). Previously diagnosed AHP patients have a significantly milder attack course as compared to previously undiagnosed patients. Family screening following sentinel cases might prevent severe AHP attacks.

Indexed as

Early DiagnosisAdolescentAdultFemaleHumansHyponatremiaIntensive Care UnitsIsraelLength of StayMaleMental DisordersMiddle AgedPorphobilinogen SynthasePorphyrias, HepaticPrevalenceRetrospective StudiesPorphobilinogen SynthaseDiagnosisIntensive carePorphobilinogenPorphyria

Identifiers

PMID32372331
OpenAlexW3022793478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.